CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $31,045,127 | +2453.4% | 808,046 | +1438.5% | 0.01% | +1200.0% |
Q1 2023 | $1,215,838 | -11.6% | 52,520 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,376,024 | +99.4% | 52,520 | +49.5% | 0.00% | – |
Q3 2022 | $690,000 | +12.4% | 35,120 | 0.0% | 0.00% | – |
Q2 2022 | $614,000 | +11.0% | 35,120 | +3.8% | 0.00% | – |
Q1 2022 | $553,000 | +0.5% | 33,820 | +0.3% | 0.00% | – |
Q4 2021 | $550,000 | +36.5% | 33,720 | +6.6% | 0.00% | – |
Q3 2021 | $403,000 | -9.6% | 31,620 | 0.0% | 0.00% | – |
Q2 2021 | $446,000 | +18.6% | 31,620 | +30.6% | 0.00% | – |
Q1 2021 | $376,000 | -2.1% | 24,220 | 0.0% | 0.00% | – |
Q4 2020 | $384,000 | – | 24,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |